ICL Israel Chemicals Ltd
ICL Group Ltd, together with its subsidiaries, operates as a specialty minerals and chemicals company worldwide. The company operates in four segments: Industrial Products, Potash, Phosphate Solutions, and Growing Solutions. The Industrial Products segment produces bromine out of a solution that is a by-product of the potash production process, as well as bromine-based compounds; sells various gr… Read more
Market Cap & Net Worth: ICL Israel Chemicals Ltd (ICL)
ICL Israel Chemicals Ltd (NYSE:ICL) has a market capitalization of $6.88 Billion ($6.88 Billion) as of March 18, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #3362 globally and #2223 in its home market, demonstrating a 7.89% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ICL Israel Chemicals Ltd's stock price $5.33 by its total outstanding shares 1290672729 (1.29 Billion).
ICL Israel Chemicals Ltd Market Cap History: 2015 to 2026
ICL Israel Chemicals Ltd's market capitalization history from 2015 to 2026. Data shows growth from $3.19 Billion to $6.88 Billion (4.59% CAGR).
ICL Israel Chemicals Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ICL Israel Chemicals Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.03x
ICL Israel Chemicals Ltd's market cap is 1.03 times its annual revenue
0.24x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
32.61x
ICL Israel Chemicals Ltd's market cap is 32.61 times its annual earnings
5.25x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $3.37 Billion | $5.36 Billion | -$122.00 Million | 0.63x | N/A |
| 2017 | $3.43 Billion | $5.42 Billion | $364.00 Million | 0.63x | 9.41x |
| 2018 | $4.99 Billion | $5.56 Billion | $1.24 Billion | 0.90x | 4.02x |
| 2019 | $4.41 Billion | $5.27 Billion | $475.00 Million | 0.84x | 9.28x |
| 2020 | $4.76 Billion | $5.04 Billion | $11.00 Million | 0.94x | 432.76x |
| 2021 | $9.96 Billion | $6.96 Billion | $783.00 Million | 1.43x | 12.72x |
| 2022 | $8.26 Billion | $10.02 Billion | $2.16 Billion | 0.83x | 3.83x |
| 2023 | $6.27 Billion | $7.54 Billion | $647.00 Million | 0.83x | 9.69x |
| 2024 | $6.38 Billion | $6.84 Billion | $407.00 Million | 0.93x | 15.67x |
| 2025 | $7.37 Billion | $7.15 Billion | $226.00 Million | 1.03x | 32.61x |
Competitor Companies of ICL by Market Capitalization
Companies near ICL Israel Chemicals Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to ICL Israel Chemicals Ltd by market ranking:
- Corteva Inc (NYSE:CTVA): Ranked #410 globally with a market cap of $53.03 Billion USD.
- Nutrien Ltd (NYSE:NTR): Ranked #611 globally with a market cap of $34.02 Billion USD.
- Yunnan Yuntianhua Co Ltd (SHG:600096): Ranked #2302 globally with a market cap of $6.52 Billion USD ( CN¥47.86 Billion CNY).
- Qinghai Salt Lake Industry Co.Ltd (SHE:000792): Ranked #1141 globally with a market cap of $16.80 Billion USD ( CN¥123.30 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Corteva Inc | NYSE:CTVA | $53.03 Billion | $79.04 |
| #611 | Nutrien Ltd | NYSE:NTR | $34.02 Billion | $77.79 |
| #2302 | Yunnan Yuntianhua Co Ltd | SHG:600096 | $6.52 Billion | CN¥43.13 |
| #1141 | Qinghai Salt Lake Industry Co.Ltd | SHE:000792 | $16.80 Billion | CN¥37.33 |
ICL Israel Chemicals Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, ICL Israel Chemicals Ltd's market cap moved from $3.19 Billion to $ 6.88 Billion, with a yearly change of 4.59%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $6.88 Billion | -6.65% |
| 2025 | $7.37 Billion | +15.59% |
| 2024 | $6.38 Billion | +1.68% |
| 2023 | $6.27 Billion | -24.12% |
| 2022 | $8.26 Billion | -17.05% |
| 2021 | $9.96 Billion | +109.28% |
| 2020 | $4.76 Billion | +7.98% |
| 2019 | $4.41 Billion | -11.60% |
| 2018 | $4.99 Billion | +45.52% |
| 2017 | $3.43 Billion | +1.55% |
| 2016 | $3.37 Billion | +5.82% |
| 2015 | $3.19 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of ICL Israel Chemicals Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.88 Billion USD |
| MoneyControl | $6.88 Billion USD |
| MarketWatch | $6.88 Billion USD |
| marketcap.company | $6.88 Billion USD |
| Reuters | $6.88 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.